by Joel Rothman | Sep 25, 2006 | NutriSupLaw
Several press stories on the web report that the male enhancement supplement Nasutra has been recalled. The manufacturer claims several lots of Nasutra were tested and preliminarily found to contain Acetildenafil, an analogue of Sildenafil, the active pharmaceutical...
by Joel Rothman | Sep 18, 2006 | NutriSupLaw
The infomercial is a popular marketing vehicle for nutraceuticals and alternative medical devices. Recently, unscrupulous infomercial marketers have come under attack for unfair and deceptive trade practices. These two examples provide important lessons for makers of...
by Joel Rothman | Sep 12, 2006 | NutriSupLaw
The National Law Journal has published an interesting article entitled “Blogs are liberating the profession from dull writing – They’re emerging as a powerful tool for lawyers and law professors,” by Douglas A. Berman. The article quotes two...
by Joel Rothman | Sep 7, 2006 | NutriSupLaw
FDA issued this press release yesterday regarding a seizure at Florida supplement company Advantage Nutraceuticals, LLC. The press release doesn’t say which part of FDA this comes from but one would assume it originates in the Center for Food Safety and Applied...
by Joel Rothman | Aug 30, 2006 | NutriSupLaw, patents
Trade secret and patent protection for nutraceuticals. Can’t get more current than that. And three lawyers from Foley & Lardner provide info on both in a pair of articles published in the last week or so. First there’s “Keeping trade secrets...
by Joel Rothman | Aug 29, 2006 | NutriSupLaw
In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA’s ban on low dose ephedra was not arbitrary or capricious. Next stop, Supreme Court? Neutraceutical Corp. v. Von...
